Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
9.050 - 9.100
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
ISTA Pharmaceuticals Stockholders Vote to Approve Acquisition by Bausch + Lomb
June 05, 2012
from
Marketwired News Releases
ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 10, 2012
from
Marketwired News Releases
More News
Read More
ISTA Pharmaceuticals Reports First Quarter 2012 Financial Results
May 03, 2012
from
Marketwired News Releases
ISTA Pharma (ISTA) Reports Positive Results from BEPOSONE Phase 2
May 01, 2012
from
StreetInsider.com News Articles
ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of BEPOSONE(TM) Nasal Spray for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis
May 01, 2012
from
Marketwired News Releases
Bausch + Lomb, ISTA Pharma (ISTA) Get Early HSR Termination
April 23, 2012
from
StreetInsider.com News Articles
Bausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting Period
April 23, 2012
from
Marketwired News Releases
ISTA Pharma (ISTA) Reports Positive Results from Phase 3 Study of PROLENSA, to File New NDA in 1H'12
April 23, 2012
from
StreetInsider.com News Articles
ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 American Society of Cataract and Refractive Surgery (ASCRS) Symposium and Congress
April 23, 2012
from
Marketwired News Releases
RLPC: Bausch and Lomb preps $3.485B credit
April 17, 2012
category
companyNews
from
Reuters: Company News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.